Deciphera Pharmaceuticals Announces Appointment of Ron Squarer to its Board of Directors
Deciphera Pharmaceuticals, Inc. (DCPH)
Last deciphera pharmaceuticals, inc. earnings: 3/9 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
deciphera.com/investor-relations
Company Research
Source: Business Wire
- Former CEO of Array BioPharma Brings Expertise in Oncology Drug Development and Commercialization - WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (Nasdaq:DCPH), a clinical-stage biopharmaceutical company addressing key mechanisms of tumor drug resistance, today announced that it has appointed Ron Squarer to its Board of Directors. Mr. Squarer served as Chief Executive Officer and a member of the Board of Directors of Array BioPharma, Inc. (Array) from 2012 until its acquisition by Pfizer Inc. (Pfizer) in August 2019 following the successful commercial launches of both Braftovi® and Mektovi®.“Ron brings over two decades of experience in the biopharmaceutical industry to our Board of Directors, with a focus and expertise in oncology drug development, commercialization, and new product launches,” said Steve Hoerter, President and Chief Executive Officer of Deciphera. “We look forward to his valuable insights as we build our commercial organization and advance our
Show less
Read more
Impact Snapshot
Event Time:
DCPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DCPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DCPH alerts
High impacting Deciphera Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
DCPH
News
- Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates Fri, May 10, 2024, 2:50 PM GMT+2 3 min read 0 In this article: Advertisement Up next Analyst adjusts Nvidia stock price target ahead of earnings Fri, May 10, 2024, 1:03 AM GMAcquire Media Monitor
- Here's What Key Metrics Tell Us About Deciphera Pharmaceuticals (DCPH) Q1 Earnings [Yahoo! Finance]Yahoo! Finance
- SHAREHOLDER ALERT: Weiss Law Investigates Deciphera Pharmaceuticals, Inc.Accesswire
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DCPH, HTLF, DPSI, UNITGlobeNewswire
- Lifshitz Law PLLC Announces Investigations of DCPH, SLCA, HCP, and HTLFAccesswire
DCPH
Earnings
- 5/10/24 - Beat
DCPH
Sec Filings
- 5/10/24 - Form 10-Q
- 5/6/24 - Form SC
- 4/30/24 - Form SC
- DCPH's page on the SEC website